Categories: News

CryptoZR, The World’s First Artist to Stage A Solo Exhibition on CryptoArt, to Sell 1000EYE to 1,000 Collectors Simultaneously

BEIJING, CHINA- Media OutReach-�24 September 2021 – Following CryptoZR’s (Liu Jiaying) exhibition Cookie Cookie, the world’s first CryptoArt themed exhibition held in Beijing in May 2021 the artist will sell her work 1000E YE, which was one of the works on display. Collectors will have the chance to purchase a part of the work from September 26, 2021 at 9 pm Beijing time / 2 pm BST to September 29, 2021 at 9 pm Beijing time / 2 pm BST.

Left: 1000EYE(2019), Oil painting, 3m diameter; Right: Eye of Satoshi Nakamoto, ( 100EYEclose-up)
Courtesy of CryptoZR

In 2019, CryptoZR created 1000EYE , a CryptoArt project based on Ethereum blockchain. Starting with the eye of Satoshi Nakamoto, a pseudonym of the father of Bitcoin, CryptoZR painted 1,000 eyes on a canvas arranged in a Ulam Spiral, essentially “homogenizing” all subjects in the painting. Once the painting was completed, the artist anonymized each eye and issued 1,000 corresponding non-fungible tokens (NFT). Stored on an Ethereum blockchain and with each eye representing a one-thousandth unit of the work, 1000EYE can be divided into independent entities in the blockchain. Conversely, the work as a whole, can last forever in the blockchain world through its decentralized characteristics.

To ensure fairness of distribution, the artist will use the closing price on the issuance date from Nasdaq’s first trading day after the sale period of the work to randomly assign numbers to the images of the 1000 NFTs, information to which even the artist herself has not been made not privy. The tokenID corresponding to each eye will be made available the day after the work is sold on the first trading day. The price of each eye work in 1000EYE is unilaterally priced at 1 Ether (ETH). The address of the numbered artworks, ranging from 1 to 1000, will be announced on Twitter @crypto1000eye , where collectors can access the sales website via the announcement and inquire about the works on sale.

CryptoZR said: ” 1000EYE is about decentralization and to evoke discussions around the dissolution of power. In the real world, not everyone knows who Satoshi Nakamoto is, but in this work, everyone will know who Nakamoto is. I homogenize the “non-fungible” characters, striving to reflect the relationship between virtual and reality. As for creative techniques to depict this relationship, I use the crudest forms of manpower to paint. The time and thoughts spent are diametrically opposed to the art of algorithm.”

To download the press kit, please click:

https://egnyte.suttoncomms.com/fl/PenBspAEWt

About CryptoZR

CryptoZR (Liu Jiaying) previously served as Chief Product Designer of Global SNS in the international business department at Tencent headquarter. In 2016, she was accepted to the Central Academy of Fine Arts for a master’s degree. During her postgraduate period, the artist began using fundamental blockchain technology to explore a unique artistic language. In 2020, CryptoZR earned her master’s degree from the Central Academy of Fine Arts. The following year, she staged the world’s first ever physical CryptoArt solo exhibition at the Guardian Art Center in Beijing .

Facebook: https://www.facebook.com/CryptoZR

Instagram: https://www.instagram.com/cryptozr_/

Twitter: https://twitter.com/cryptoZR_

#CryptoZR #LiuJiaying #1000EYE #CryptoArt #NFTart #BlockchainArt

Miscw.com

Recent Posts

SK hynix and HLDS Jointly Developed Tube T31 and Haechi H02 Win Red Dot Design Award and Exhibit at COMPUTEX

SEOUL, South Korea--(BUSINESS WIRE)--Leading semiconductor company SK hynix today announced that its stick-type SSD, the…

28 mins ago

NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+

LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic…

30 mins ago

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA)…

31 mins ago

LiveSpo Pharma Emerges as Vietnam’s Pioneer at Vitafoods Europe 2024

Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care…

47 mins ago

DHL Global Forwarding announces management appointments in Asia Pacific

Effective 1 May 2024, Vincent Yong, previously President Director, DHL Global Forwarding Indonesia, assumes the…

2 hours ago